recent articles
Paige PanCancer Detect recognized by FDA as a Breakthrough Device intended to assist pathologists in the detection of cancer across multiple tissue and organ types NEW YORK--(BUSINESS WIRE)--Paige, a leader in next-generation AI...
Article Published in Nature Medicine Provides Further Scientific Evidence for Deployment of Computational Decision Support Systems to Improve Patient Care NEW YORK, July 15, 2019 – Paige, the leader in computational pathology focused on...
Congratulations to Paige.AI for obtaining Breakthrough Device designation. My recollection from a final guidance issued by the FDA late last year and taken from their own news release: "The [Breakthrough Device] program was established by the...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing